Evidence map›Paper›PMID 36928522›Full record

ArticleThe Journal of experimental medicine2023

Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms.

Keenan A Lacey, Lee Serpas, Sohei Makita, Yueyang Wang, Ali Rashidfarrokhi, Chetna Soni, Sandra Gonzalez, Andre Moreira, Victor J Torres, Boris Reizis

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. ImagingmBio · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Structural characteristics, functions, and counteracting strategies of biofilms inComputational and structural biotechnology journal · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Approaches to combating methicillin-resistantExpert opinion on investigational drugs · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Keenan A Lacey *Department of Microbiology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0002-9242-0170
Lee Serpas *Department of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0002-1278-2893
Sohei Makita *Department of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0001-9752-4385
Yueyang WangDepartment of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0002-8456-1440
Ali RashidfarrokhiDepartment of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0002-9357-8594
Chetna SoniDepartment of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0001-7800-2338
Sandra GonzalezDepartment of Microbiology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0009-0002-0884-4200
Andre MoreiraDepartment of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0003-1857-3774
Victor J TorresDepartment of Microbiology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0002-7126-0489
Boris ReizisDepartment of Pathology, New York University Grossman School of Medicine , New York, NY, USA.ORCID 0000-0003-1140-7853
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Medical Scientist Research Service AwardT32GM136573 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SULMAN, ERIK · 2020 to 2024
$6.8M
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)P50AR070591 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2017 to 2021
$6.7M
Mechanistic Studies Of The Staphylococcus aureus LukAB CytotoxinR01AI099394 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Victor J. Torres · 2013 to 2026
$6.1M
Redefining the role of autophagy in bacterial diseaseR01AI121244 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 2017 to 2026
$5.6M
Contribution of LukED to Staphylococcus aureus pathobiologyR01AI105129 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TORRES, VICTOR J. · 2014 to 2023
$4.9M
Training Program in Immunology and Inflammation.T32AI100853 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Susan Ruth Schwab · 2012 to 2026
$4.5M
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus ErythematosusR01AR071703 · NIAMS · UNIVERSITY OF CHICAGO · PI Jill P Buyon, GEORGE Georgiou GEORGIOU · 2018 to 2026
$4.4M
Host-pathogen interactions during hospital adaptation of MRSAR01AI137336 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHOPSIN, BO, YANAI, ITAI · 2019 to 2022
$3.3M
Translational Basic and Clinical Research Training in RheumatologyT32AR069515 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Jill P Buyon, Jose U. Scher · 2017 to 2026
$2.9M
Scanning Electron Microscope with 3ViewS10OD019974 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIANG, FENGXIA · 2016 to 2016
$1.1M
NCI NIH HHS P30 CA016087NIAID NIH HHS HHSN272200700055CNIAID NIH HHS R01 AI099394NIAID NIH HHS R01 AI105129NIAID NIH HHS R01 AI121244NIAID NIH HHS R01 AI137336NIAID NIH HHS T32 AI100853NIAMS NIH HHS P50 AR070591NIAMS NIH HHS R01 AR071703NIAMS NIH HHS T32 AR069515NIGMS NIH HHS T32 GM136573NIH HHS S10 OD019974
6 · The paper itself

Abstract

Extracellular DNase DNASE1L3 maintains tolerance to self-DNA in humans and mice, whereas the role of its homolog DNASE1 remains controversial, and the overall function of secreted DNases in immunity is unclear. We report that deletion of murine DNASE1 neither caused autoreactivity in isolation nor exacerbated lupus-like disease in DNASE1L3-deficient mice. However, combined deficiency of DNASE1 and DNASE1L3 rendered mice susceptible to bloodstream infection with Staphylococcus aureus. DNASE1/DNASE1L3 double-deficient mice mounted a normal innate response to S. aureus and did not accumulate neutrophil extracellular traps (NETs). However, their kidneys manifested severe pathology, increased bacterial burden, and biofilm-like bacterial lesions that contained bacterial DNA and excluded neutrophils. Furthermore, systemic administration of recombinant DNASE1 protein during S. aureus infection rescued the mortality of DNase-deficient mice and ameliorated the disease in wild-type mice. Thus, DNASE1 and DNASE1L3 jointly facilitate the control of bacterial infection by digesting extracellular microbial DNA in biofilms, suggesting the original evolutionary function of secreted DNases as antimicrobial agents.

Indexed as

BiofilmsEndodeoxyribonucleasesSepsisStaphylococcal InfectionsAnimalsDeoxyribonuclease IDeoxyribonucleasesDNAExtracellular TrapsMammalsMiceStaphylococcus aureusDeoxyribonuclease IDeoxyribonucleasesDNADnase1l3 protein, mouseEndodeoxyribonucleases

Identifiers

PMID36928522
PMCPMC10037111
OpenAlexW4327587507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.